Dr. Collins discusses advances in treatments for Hodgkin Lymphoma.
Dr. Graham Collins, an Associate Professor of hematology and lymphoma lead clinician in Oxford, UK, trained in Cambridge, London, and Oxford and did research into the molecular biology of the Reed-Sternberg cell. He is past chair of the Hodgkin lymphoma national study group and runs a number of clinical trials looking at different treatment approaches for this disease. He has co-authored a number of guidelines for various types of lymphoma including Hodgkin lymphoma.
